載入...

Glucose Control and Cardiovascular Outcomes in Clinical Trials of Sodium Glucose Co-transporter 2 Inhibitor Treatments in Type 2 Diabetes

Currently available medications for the treatment of type 2 diabetes have limitations, and many patients do not achieve glycaemic control. Recently, a new approach has emerged using sodium glucose co-transporter 2 (SGLT2) inhibitors that decrease glucose reabsorption in the kidneys, increasing urina...

全面介紹

Na minha lista:
書目詳細資料
發表在:Eur Endocrinol
Main Authors: A Oliveros, Rene, V Pham, Son, R Bailey, Steven, J Chilton, Robert
格式: Artigo
語言:Inglês
出版: Touch Medical Media 2014
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5983080/
https://ncbi.nlm.nih.gov/pubmed/29872475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17925/EE.2014.10.02.117
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!